Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis
Sponsor: Mayo Clinic
A observational or N/A phase clinical study on Colitis, Ulcerative and IBD, this trial is completed. The trial is conducted by Mayo Clinic and has accumulated 18 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
18 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
-
Jun 2022 — Dec 2022 [monthly]
Completed
▶ Show 13 earlier versions
-
May 2022 — Jun 2022 [monthly]
Completed
-
Apr 2022 — May 2022 [monthly]
Completed
-
Dec 2021 — Apr 2022 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jan 2020 — Nov 2020 [monthly]
Completed
Status: Recruiting → Completed
-
Dec 2018 — Jan 2020 [monthly]
Recruiting
-
Jun 2018 — Dec 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Feb 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
May 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .